Clinical Trials: Availability, Volunteers, Drug Research Document List

Clinical Trial Research Publications - (75 Articles)

• Disabled Commonly Excluded From Clinical Trial Eligibility
  Despite constituting the largest minority group in the U.S. and expressing interest in participating in clinical trials, people with disabilities remain excluded.
  Publish Date: 2022-10-03 - Updated: 2023-01-04

• New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment
  Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment.
  Publish Date: 2020-01-07 - Updated: 2020-02-10

• Clinical Trial Recognizes Needs of Severely Disabled MS Patients
  New clinical trial testing disease modifying drug for multiple sclerosis (MS) first in the world to recognize importance of wheelchair users retaining use of their hands.
  Publish Date: 2018-06-16

• Intensity Therapeutics Human Cancer Clinical Trial Update
  Intensity Therapeutics a private biotech firm is way ahead of big pharma and universities with human cancer immuno oncology clinical trials.
  Publish Date: 2018-03-26

• Fighting My Cancer as Much as Possible - Why Many Patients Join Phase 1 Clinical Trials
  According to research presented at TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France - Fighting my cancer as much as possible - is why many patients participate in early stage clinical trials.
  Publish Date: 2018-03-23

• Pediatric Neural Tumor Shrinkage Shown in Selumetinib Clinical Trial
  Early-phase clinical trial of selumetinib in children with common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas.
  Publish Date: 2016-12-29 - Updated: 2018-06-20

• Antidote: A Digital Health Company on a Mission
  Antidote matches the right patients with the right clinical trials, helping medical researchers make faster progress, and offering new treatment options to patients.
  Publish Date: 2016-09-22 - Updated: 2017-06-01

• Evaluating FDA Approach to Cancer Clinical Trials
  U.S. FDA is committed to meet needs of patients and health care communities in prevention, diagnosis, and treatment of cancer.
  Publish Date: 2016-09-17

• AST-OPC1 Clinical Study for Spinal Cord Injury Patients
  Asterias Biotherapeutics AST-OPC1 treatment for spinal cord injury patients shown to help paralyzed patients regain function in arms and hands.
  Publish Date: 2016-09-14 - Updated: 2021-05-08

• UK Clinical Trial to Test Treatments for Vitiligo
  We are looking for people who have at least one patch of vitiligo that has appeared or worsened over the past year.
  Publish Date: 2016-06-18 - Updated: 2018-03-15

• Largest Autism Clinical Trial in History Extends Recruitment Target
  Mental Imagery Therapy for Autism (MITA), an early-intervention application for children with ASD, is currently being validated in the clinical trial.
  Publish Date: 2016-06-15 - Updated: 2018-05-01

• Clinical Trials of Robotic Legs Help Patients Walk Again
  Clinicians and engineers at University of Kent carrying out first clinical trials of robotic legs for patients.
  Publish Date: 2016-05-26

• Clinical Trials: Seeking Female Diversity
  It is important for more women, particularly those of diverse ethnicities, to take part in clinical trials.
  Publish Date: 2016-05-03

• First US Clinical Trial for Lewy Body Dementia
  HEADWAY-DLB is a phase 2b multi-center, double-blind, placebo-controlled study to evaluate investigational medicine RVT-101 for dementia with Lewy bodies.
  Publish Date: 2016-04-25

• SCI Researcher Seeking Volunteers with Spinal Cord Injuries
  Spinal cord injury researcher is seeking participants with spinal cord injuries for the final phase of her doctoral research.
  Publish Date: 2016-04-18

• Study to Control and Prevent Urinary Symptoms in People with Spinal Cord Injury and Disease
  United Spinal Association recruiting people with spinal cord injury and disease for a study to control and prevent urinary symptoms.
  Publish Date: 2016-03-19

• FDA Grants Therapy Designation for Ocrelizumab in Primary Progressive MS
  FDA grants breakthrough therapy designation for the investigational medicine Ocrelizumab (OCREVUS) for treatment of primary progressive multiple sclerosis (PPMS).
  Publish Date: 2016-02-17 - Updated: 2020-11-14

• Argus II Bionic Eye Clinical Trial Results
  Results of 3 year clinical trial study of retinal implant known as the Argus II bionic eye for people blinded by retinitis pigmentosa.
  Publish Date: 2015-06-23 - Updated: 2017-06-26

• Early Clinical Trials Find Powdered Measles Vaccine Safe
  Measles vaccine made of fine dry powder delivered with puff of air triggered no adverse side effects in early human testing and it is likely effective.
  Publish Date: 2014-11-29

• ELND005 Clinical Study in Youth with Down Syndrome Results
  Transition announce results of clinical study of neuropsychiatric drug candidate ELND005 in young adults with Down syndrome.
  Publish Date: 2014-11-20 - Updated: 2021-10-13

• IMC-1 Fibromyalgia Treatment Reduces Pain and Symptoms
  IMC-1 oral medication proves highly effective at reducing pain and other symptoms of fibromyalgia (FM) in patients in a recent clinical trial.
  Publish Date: 2014-11-20 - Updated: 2020-12-13

• Pain Relief for Knee Osteoarthritis with Traumeel and Zeel Intra-articular Injections
  This study supports clinical feedback from healthcare professionals regarding positive outcomes with Traumeel and Zeel injections in knee osteoarthritis.
  Publish Date: 2014-11-19 - Updated: 2020-11-22

• Glyder Facet Restoration Clinical Study for Lumbar Spine
  The Glyder Device is designed to provide long-term relief of facet joint pain through a non-fusion procedure.
  Publish Date: 2014-11-12 - Updated: 2021-10-18

• Human Clinical Trial of Ebola Vaccine Started
  Researchers at NIAID are conducting early phase trial to evaluate VSV-ZEBOV Ebola virus vaccine.
  Publish Date: 2014-11-01 - Updated: 2018-01-25

• Clinical Trial of Rett Syndrome Drug Shows Promise
  Clinical trial finds a growth factor known as IGF1 can help treat some symptoms of Rett syndrome.
  Publish Date: 2014-06-23

• Cerebral Palsy Clinical Trial Using Cord Blood Stem Cell Therapy
  Recruiting efforts are underway to enroll children between the ages of 2 and 10 diagnosed with cerebral palsy in an FDA regulated clinical trial using stem cell therapy.
  Publish Date: 2014-04-19 - Updated: 2021-08-09

• EPA Experiments Seek to Harm People States AAPS
  Association of American Physicians and Surgeons states EPA is soliciting senior Americans to volunteer for experiments where the purpose is to harm people.
  Publish Date: 2014-04-11 - Updated: 2014-04-16

• Drugs Show Promise Against Aggressive Medulloblastoma Childhood Brain Tumor
  Study identified with potential to improve treatment of a high-risk childhood brain tumor are now part of pediatric clinical trial.
  Publish Date: 2014-03-27

• Therapeutic Target for Treating Huntington's and Parkinson's Disease
  Research from Western University has revealed a possible new target for treating movement disorders such as Huntington's disease (HD) and Parkinson's disease.
  Publish Date: 2014-01-08 - Updated: 2022-01-03

• BrainGate Trial to Restore Movement for People with Paralysis
  Experts in muscle stimulation technology and brain-computer interfaces working to restore movement for people with paralysis.
  Publish Date: 2013-02-22 - Updated: 2021-05-23

• Autism Clinical Trial Regarding Cord Blood Stem Cells
  First FDA approved clinical trial to evaluate use of child's own cord blood stem cells to treat patients with autism.
  Publish Date: 2012-08-25 - Updated: 2021-08-04

• Landmark Clinical Study in Spinal Cord Injury - Asubio
  Phase 2 clinical trial of SUN13837 an investigational medication developed to improve neurological function in patients with newly diagnosed acute spinal cord injury.
  Publish Date: 2012-04-23 - Updated: 2012-09-19

• Oral Laquinimod Drug May Ease Multiple Sclerosis Disability
  Laquinimod has been shown to be effective in treating the progression of Multiple Sclerosis (MS) for patients with relapsing remitting forms of the disease.
  Publish Date: 2012-04-04 - Updated: 2021-09-26

• New HIV Vaccine - Human Trials Initiated
  The trial funded by the Wellcome Trust called MUCOVAC2 is evaluating a vaccine that contains the HIV trimeric gp140 protein CN54 representative of Clade C strains of the virus.
  Publish Date: 2011-12-21 - Updated: 2013-08-01

• Artificial Pancreas System Clinical Trials - FDA Outlines Flexible Approaches
  Draft guidance designed to help investigators and manufacturers to develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.
  Publish Date: 2011-12-02

• New Cancer Vaccine Receives Approval for Clinical Tests and Secures Substantial Financing
  Immunicum which is developing cancer vaccines has received approval to test the vaccine on humans for the first time.
  Publish Date: 2011-11-26 - Updated: 2013-06-14

• ACTEMRA Monotherapy Improves Symptoms of Rheumatoid Arthritis
  Data from Phase III clinical trials in rheumatoid arthritis patients who received ACTEMRA (tocilizumab) as monotherapy and those who received ACTEMRA plus antirheumatic drug (DMARD), including methotrexate (MTX).
  Publish Date: 2011-11-07 - Updated: 2022-06-10

• Examining Meds to Treat Social Withdrawal in Autism
  Children and adults with social withdrawal due to Fragile X syndrome or autism may benefit from an experimental drug under study.
  Publish Date: 2011-07-23 - Updated: 2022-02-03

• Investigational Treatment for SCI and TBI
  Acorda plans to study AC105 as an acute treatment for patients who have suffered neurological trauma such as spinal cord injury and traumatic brain injury.
  Publish Date: 2011-07-01 - Updated: 2022-02-22

• Trial of SBC-102 in Adults with Lysosomal Acid Lipase Deficiency
  Synageva BioPharma Corp. has initiated a clinical study to evaluate the safety, tolerability, and pharmacokinetics of SBC-102 as an enzyme replacement therapy for cholesteryl ester storage disease (CESD).
  Publish Date: 2011-06-06 - Updated: 2022-03-14

• First Ever Clinical Trial Approved for Spinal Muscular Atrophy
  Families of Spinal Muscular Atrophy approval from FDA to commence a Phase I safety study for RG3039 formerly called Quinazoline495 developed for Spinal Muscular Atrophy.
  Publish Date: 2011-05-19

• Dry Eye Disease - Encouraging Results of SAR 1118 Study
  We are encouraged by the clinical effects of SAR 1118 in improving both signs and symptoms of dry eye.
  Publish Date: 2011-05-04 - Updated: 2015-04-19

• Joining a Clinical Trial
  Clinical trials are research studies in which people help doctors find ways to improve health and cancer care.
  Publish Date: 2011-05-01

• Clinical Trial of SB623 Cell Therapy for Stroke Disability
  Phase 1/2a clinical trial testing safety and efficacy of Allogeneic cell therapy SB623 on patients suffering from stable deficits resulting from previous stroke injuries.
  Publish Date: 2011-04-21 - Updated: 2022-04-17

• Traumatic Brain Injury Clinical Trial Collaboration
  NeuroVive announced agreement with European Brain Injury Consortium to conduct clinical trial of NeuroSTAT for neuro-protection in patients with traumatic brain injury (TBI).
  Publish Date: 2011-03-08

• Clinical Trial to Find Best Way of Treating Arm Pain
  More than 500 people suffering from lower arm pain are to take part in a new UK-wide clinical trial.
  Publish Date: 2011-02-10

• Neuralstem ALS Clinical Trial Update
  Neuralstem reports the progress of ongoing Phase I human clinical trial of spinal cord stem cells in the treatment of Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease.
  Publish Date: 2011-02-10 - Updated: 2022-06-06

• Clinical Trial For Rett Syndrome Launched
  Study marks the emergence of disease-modifying treatments for autism spectrum disorders.
  Publish Date: 2010-12-16

• Can Aspirin Prolong a Healthy Life
  The Aspirin in Reducing Events in the Elderly study will assess whether aspirin can prolong life and if it can prolong a life free of physical disability and dementia for healthy older people.
  Publish Date: 2010-11-07

• Curemark Adds Two Autism Trial Sites in California
  Curemark announces it has added two sites in California to its Phase III clinical trial program for CM-AT autism treatment.
  Publish Date: 2010-10-28

• Parents Experience Difficulty with Pediatric Cancer Trials Consent Process
  Compared with adult cancer patients parents of children with cancer were more likely to be dissatisfied with consent process for participating in clinical trials.
  Publish Date: 2010-10-22

• Reovirus Appears to Have a Redemptive Quality - The Ability to Kill Cancer
  Reovirus that can cause coughing and mild diarrhea appears to have a major redemptive quality - the ability to kill cancer.
  Publish Date: 2010-10-20

• Novartis Once-Yearly Reclast Preserves Bone Mass and Fracture Protection in Postmenopausal Osteoporosis
  Long-term data show novartis once-yearly reclast preserves bone mass and provides fracture protection in postmenopausal osteoporosis.
  Publish Date: 2010-10-17

• Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
  New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease.
  Publish Date: 2010-10-03

• Genital Herpes Vaccine Ineffective in Women
  An experimental vaccine intended to prevent genital herpes disease in women although generally safe and well-tolerated proved ineffective.
  Publish Date: 2010-10-01

• Abatacept Ineffective in Non-life Threatening Lupus Treatment
  Abatacept found ineffective in treatment of non-life threatening lupus further trials needed to determine clinical application of drug in SLE.
  Publish Date: 2010-09-29

• Drug Trial Offers Hope for Heart Attack Patients
  New findings from major drug trial a step closer to developing a drug which could prevent thousands of deaths from heart attacks.
  Publish Date: 2010-09-13

• First Clinical Trials Successfully Completed on Potent New hepatitis C Drug
  First clinical trials on a new drug being developed to treat infections caused by Hepatitis C virus successfully completed.
  Publish Date: 2010-09-03

• Success Stops Apixaban Drug Trial
  Evidence of success of apixaban in prevention of stroke in patients with atrial fibrillation who are unsuitable for treatment of warfarin.
  Publish Date: 2010-08-31

• Spinal Cord Injury Stem Cell Trial - Neuralstem Files FDA Application
  Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells.
  Publish Date: 2010-08-25 - Updated: 2010-08-26

• Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets
  Study found tapentadol ER was associated with a lower overall incidence of gastrointestinal adverse events than oxycodone CR.
  Publish Date: 2010-07-19 - Updated: 2014-03-15

• Clinical Trial Matching Service for Alzheimer's
  The Alzheimer's Association announced today the launch of Alzheimer's Association TrialMatch.
  Publish Date: 2010-07-12

• Autism Families with New Pregnancies Sought for Vitamin D Research
  Study to see if giving Vitamin D to pregnant mother can prevent recurrence of autism in the newborn sibling.
  Publish Date: 2010-06-28

• Trial of Gene Therapy for Parkinson's Disease Successful
  Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease.
  Publish Date: 2010-06-22 - Updated: 2017-09-22

• Curemark Begins Autism Trials at Two More Sites
  Curemark is a drug research and development company focused on the treatment of neurological and other diseases.
  Publish Date: 2010-06-01

• New Hepatitis C Drug Trials Begin
  Clinical trials have started on a new drug which is being developed to treat infections caused by Hepatitis C virus.
  Publish Date: 2010-05-14

• Total Spine Arthroplasty System Trial
  First approved clinical study for a Total Spine Arthroplasty system in the U.S..
  Publish Date: 2010-04-22

• MS Patients Receiving Alemtuzumab Remain Free of Clinically-Active Disease
  Multiple sclerosis (MS) trial showed 71 percent of alemtuzumab treated patients remain free of clinically-active disease for three years.
  Publish Date: 2010-04-14

• Cordis Trial of New Stent Graft System
  First patients enrolled in cordis trial of new stent graft system to treat abdominal aortic aneurysm.
  Publish Date: 2010-04-09 - Updated: 2015-03-18

• Stroke Treatment Passes Safety Stage of Clinical Trial
  Clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage.
  Publish Date: 2010-03-10

• MIRAPEX ER Approved for Treatment of Early Parkinson's Disease
  FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinsons Disease.
  Publish Date: 2010-02-22

• VLP Pandemic Influenza Vaccine Study - Novavax
  Immunogenicity data from Pivotal 2009 A/H1N1 VLP pandemic influenza vaccine study in Mexico.
  Publish Date: 2010-02-19

• Stroke Clinical Trial in UK
  First-in-man clinical trial with its ReN001 stem cell therapy for stroke.
  Publish Date: 2010-02-11

• TOPICA'S Luliconazole IND to Begin Clinical Trials in Onychomycosis
  Trial for use of luliconazole in patients with onychomycosis nail and nail bed fungal infections.
  Publish Date: 2010-02-01

• Treatment of Advanced Waldenstrom's Macroglobulinemia - Clinical Trial
  Positive Phase 2 Study Results of Perifosine as Single Agent for Treatment of Advanced Waldenstroms Macroglobulinemia.
  Publish Date: 2010-01-27 - Updated: 2017-02-03